AR038899A1 - Un medicamento para animales - Google Patents

Un medicamento para animales

Info

Publication number
AR038899A1
AR038899A1 ARP030100790A ARP030100790A AR038899A1 AR 038899 A1 AR038899 A1 AR 038899A1 AR P030100790 A ARP030100790 A AR P030100790A AR P030100790 A ARP030100790 A AR P030100790A AR 038899 A1 AR038899 A1 AR 038899A1
Authority
AR
Argentina
Prior art keywords
particles
animal
coated
production
active ingredient
Prior art date
Application number
ARP030100790A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27798784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR038899(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR038899A1 publication Critical patent/AR038899A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

Suministro y producción de un medicamento para animales que consiste en un sustrato en forma de gránulo o tableta, que es atractivo para el ganado y los animales domésticos, en donde se empotran partículas de grano fino de un material de vehículo sólido de sabor neutro, fisiológicamente compatible, que se caracteriza porque las partículas de grano fino del material de vehículo tienen un diámetro promedio de 0,09 a 0,8 milímetros, y se recubren con una sustancia activa de medicina veterinaria, y esta capa de sustancia activa se cubre con una capa protectora de una matriz polimérica fisiológicamente compatible y a la producción de este medicamento para animales. Uso de estas partículas de grano fino doblemente recubiertas de material de vehículo en la producción de una preparación para medicina veterinaria. Reivindicación (10): Un proceso para la producción de un medicamento para animales de acuerdo con una de las reivindicaciones 1 a 9, caracterizado porque: (1) se recubren partículas con un diámetro promedio de 0,09 a 0,8 milímetros de un material de vehículo sólido de sabor neutro, fisiológicamente compatible, con un ingrediente activo o una mezcla de ingredientes activos para medicina veterinaria, de tal manera que el ingrediente activo encierre a las partículas. (2) este recinto de ingrediente activo se recubre con una capa protectora enmascaradora consistente en una matriz polimérica fisiológicamente compatible, la cual impide el contacto directo del ingrediente activo con las células gustativas y olfativas y la saliva del animal; (3) estas partículas doblemente recubiertas se mezclan íntimamente con un sustrato que sea atractivo para el animal; y (4) la mezcla consistente en sustrato y partículas doblemente recubiertas se comprime en unidades administrables de un tamano apropiado.
ARP030100790A 2002-03-11 2003-03-07 Un medicamento para animales AR038899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02005511 2002-03-11

Publications (1)

Publication Number Publication Date
AR038899A1 true AR038899A1 (es) 2005-02-02

Family

ID=27798784

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100790A AR038899A1 (es) 2002-03-11 2003-03-07 Un medicamento para animales

Country Status (22)

Country Link
US (2) US20050169971A1 (es)
EP (2) EP1803448A3 (es)
JP (1) JP4663985B2 (es)
KR (1) KR20040101302A (es)
CN (1) CN1652754B (es)
AR (1) AR038899A1 (es)
AT (1) ATE390129T1 (es)
AU (1) AU2003218722B2 (es)
BR (1) BR0308378B1 (es)
CA (1) CA2478811C (es)
CO (1) CO5400144A1 (es)
DE (1) DE60319969T2 (es)
DK (1) DK1490037T3 (es)
ES (1) ES2301784T3 (es)
MX (1) MXPA04008845A (es)
NZ (1) NZ535167A (es)
PT (1) PT1490037E (es)
RU (1) RU2318498C2 (es)
SI (1) SI1490037T1 (es)
TW (1) TWI309557B (es)
WO (1) WO2003075895A1 (es)
ZA (1) ZA200407010B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713508A2 (en) * 2004-01-29 2006-10-25 Biosynexus Incorporated Use of amino-oxy functional groups in the preparation of vaccine conjugates
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
CA2569961A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc Controlled release pharmaceutical formulation
US20070212416A1 (en) * 2004-06-10 2007-09-13 Glatt Air Techniques, Inc. Controlled Release Matrix Pharmaceutical Dosage Formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP1935405A1 (en) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Orally disintegrating tablets
RU2014109079A (ru) 2011-08-12 2015-09-20 Бёрингер Ингельхайм Ветмедика Гмбх Фармацевтическая композиция с маскированным вкусом
DK2755498T3 (en) 2011-09-15 2018-05-22 Friulchem Spa COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CZ308210B6 (cs) * 2011-11-02 2020-03-04 Veterinární A Farmaceutická Univerzita Brno Farmaceutická kompozice ve formě pelet majících velikost částic v rozmezí od 0,1 do 10 mm pro perorální podání vodním živočichům a způsob její výroby
EP3034071B1 (en) 2011-12-21 2017-12-06 Elanco Tiergesundheit AG New combination
WO2013135853A1 (en) * 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical packaging product for the veterinary medical sector
EP2825159B1 (en) * 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
DK179072B1 (da) * 2012-05-08 2017-10-09 Novartis Tiergesundheit Ag Ny Behandling
FR2991179B1 (fr) 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes
WO2014053555A1 (en) 2012-10-04 2014-04-10 Novartis Ag Veterinary drug system
FR3002736B1 (fr) 2013-03-04 2015-06-26 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
FR3002735B1 (fr) 2013-03-04 2015-07-03 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
EP2925305B1 (en) 2013-12-04 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Improved pharmaceutical compositions of pimobendan
KR101687973B1 (ko) * 2015-12-08 2016-12-21 주식회사 씨티씨바이오 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN105963270B (zh) * 2016-06-30 2019-01-15 齐鲁动物保健品有限公司 一种盐酸贝那普利软咀嚼片及其制备方法
CN109673848A (zh) * 2018-12-29 2019-04-26 广州智特奇生物科技股份有限公司 一种肠溶包被材料、肠道缓释单宁酸及其制备方法
CN112220769A (zh) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 一种米尔贝肟吡喹酮风味片及其制备方法
MX2023002671A (es) 2020-09-04 2023-05-03 Elanco Us Inc Formulaciones agradables.
JP2023553202A (ja) 2020-12-08 2023-12-20 ルミナント バイオテク コーポレーション リミテッド 動物に物質を送達するための装置および方法の改善
CN113768038A (zh) * 2021-09-14 2021-12-10 江苏省协同医药生物工程有限责任公司 一种精准定量实验动物功能性饲料及制备方法与设备
JP7109827B1 (ja) * 2021-11-16 2022-08-01 株式会社ハニック・ホワイトラボ 抗ウイルス剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231466A (en) * 1962-10-26 1966-01-25 Walter H Hoffman Composition and method for treating animals and poultry
US3824233A (en) * 1972-07-06 1974-07-16 Lilly Co Eli Anthelmintic phenylhydrazones
US3937825A (en) * 1973-09-21 1976-02-10 American Cyanamid Company Anthelmintic composition and method of use
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
ATE121619T1 (de) 1990-04-11 1995-05-15 Upjohn Co Verfahren zum geschmacksabdecken von ibuprofen.
ATE217789T1 (de) 1992-06-04 2002-06-15 Smithkline Beecham Corp Angenehm schmeckende pharmazeutische zusammensetzungen
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
SI0760648T1 (en) * 1994-05-20 2002-04-30 Janssen Pharmaceutica N.V. Chewable flubendazole tablets for companion animals
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
AU4988197A (en) * 1996-10-16 1998-05-11 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compo sitions
CA2581111A1 (en) * 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB2356346A (en) * 1999-11-19 2001-05-23 Mars Uk Ltd Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
CA2439078C (en) 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
US8617587B2 (en) 2013-12-31
TW200304774A (en) 2003-10-16
ZA200407010B (en) 2006-06-28
US20100074952A1 (en) 2010-03-25
EP1490037B1 (en) 2008-03-26
AU2003218722B2 (en) 2006-08-31
WO2003075895A1 (en) 2003-09-18
RU2004130433A (ru) 2005-08-10
MXPA04008845A (es) 2004-11-26
PT1490037E (pt) 2008-05-05
US20050169971A1 (en) 2005-08-04
DK1490037T3 (da) 2008-07-21
DE60319969D1 (de) 2008-05-08
JP4663985B2 (ja) 2011-04-06
ES2301784T3 (es) 2008-07-01
BR0308378B1 (pt) 2013-12-24
NZ535167A (en) 2006-08-31
EP1490037A1 (en) 2004-12-29
DE60319969T2 (de) 2009-04-30
ATE390129T1 (de) 2008-04-15
RU2318498C2 (ru) 2008-03-10
CA2478811C (en) 2010-12-14
EP1803448A2 (en) 2007-07-04
EP1803448A3 (en) 2007-09-12
JP2005526756A (ja) 2005-09-08
CO5400144A1 (es) 2004-05-31
BR0308378A (pt) 2005-01-11
KR20040101302A (ko) 2004-12-02
CN1652754A (zh) 2005-08-10
CN1652754B (zh) 2013-05-22
CA2478811A1 (en) 2003-09-18
AU2003218722A1 (en) 2003-09-22
SI1490037T1 (sl) 2008-08-31
TWI309557B (en) 2009-05-11

Similar Documents

Publication Publication Date Title
AR038899A1 (es) Un medicamento para animales
BRPI0412211A (pt) composições de liberação controlada
ES2052656T3 (es) Una formulacion de revestimiento para la encapsulacion de sustancias bioactivas.
DK0495349T3 (da) Aktivmiddelpræparat til oral indgivelse, især til drøvtyggere
AR030557A1 (es) Una tableta en multicapa de liberacion controlada y metodo de tratamiento
EA200200595A1 (ru) Лекарственная форма с высвобождением лекарства под действием гидрогеля
AR024384A1 (es) UNA FORMA DE DOSIFICACIoN FARMACÉUTICA DE DISOLUCIoN INSTANTÁNEA Y UN MÉTODO PARA PREPARARLA
DE69803360D1 (de) Anwendungsformen zur behandlung der männlichen erektilen dysfunktion
JPH07507059A (ja) アルキル置換セルロースをベースとする持続放出性経口薬剤投与剤形
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
AR046510A1 (es) Composicion de un antagonista de vegf y un agente anti-proliferativo
WO2007067582A3 (en) Process for manufacturing chewable dosage forms for drug delivery and products thereof
EP2219626A4 (en) METHOD FOR MANUFACTURING DOSAGE FORMS FOR THE DELIVERY OF MEDICAMENTS AND PRODUCTS CONTAINING SAME
RU2010147287A (ru) Комбинированная композиция
AR011133A1 (es) MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA.
BRPI0513598A (pt) formas de dosagem em comprimidos revestidos de liberação entérica
GB2443793B (en) Product, method of manufacture and use
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
TW200635616A (en) Organic compounds
SE0950392L (sv) Sammansättning för behandling av hudåkommor
CN102369004A (zh) 银屑病的治疗
AR036838A1 (es) Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.
CN101048149A (zh) 口腔内溶解用固体制剂
CN101224185A (zh) 一种治疗实体肿瘤的伯舒替尼缓释植入剂
PE20040040A1 (es) Unidades de dosificacion de progestagenico

Legal Events

Date Code Title Description
FC Refusal